#bio pharmaceutical companies
A new Top Biopharma joined our ranks in 2011! With Genzyme swallowed up by Sanofi, Dendreon and its innovative prostate cancer therapy gained admission to the exclusive list.
As with the Top Pharma list, currency exchange flux makes it difficult to compare all of our Biopharmas, but U.S. dollar-reporting companies Amgen, Baxter, Biogen, Allergan, Alexion and Dendreon showed cumulative growth of 7% in 2011, combining for $29.0 billion in revenues. That s up from 4% in 2010 (swapping Genzyme for Dendreon).
Note: a company qualifies as a Biopharma if it makes at least 50% of its drug revenues from selling biologics and vaccines. Small-molecule companies need not apply.
Gil Y. Roth
Editor: Gil Y. Roth
Associate Editor: Kristin Brooks
Contributing Editor: Derek B. Lowe
All profiles written by Gil Roth, except Astellas and Daiichi-Sankyo, by Kristin Brooks
The Lowe Down capsules written by Derek Lowe (http://pipeline.corante.com )
Pipeline information compiled by Kristin Brooks
Revenue information compiled by Gil Roth
Photo of Avastin packaging courtesy of Roche
Top 10 Biopharma Companies
based on 2011 biopharma revenues